Clinical Trial Update: Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab [Phase 1, Phase 2]

View source ↗

Summary

This entry provides a trial update for ranibizumab in persistent diabetic macular edema after bevacizumab treatment, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (Lucentis) (ranibizumab)

Snippet

Sponsor: Southeast Retina Center, Georgia | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: UNKNOWN